celecoxib has been researched along with thiazolidines in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aktay, G; Aydın, S; Basu, A; Çevik, Ö; Coşkun, İ; Gürsoy, Ş; Kaushik-Basu, N; Küçükgüzel, ŞG; Özakpınar, ÖB; Özsavcı, D; Şener, A; Talele, TT | 1 |
| Abdelgawad, MA; Abdellatif, KR; Alsayed, SS; Elshemy, HA | 1 |
| Abdelgawad, MA; Azouz, AA; Bakr, RB; Bukhari, SNA; El-Gendy, AO; Kamel, GM | 1 |
| Ashour, HM; Fahmy, SM; Khalil, MA; Labouta, IM; Nassra, RA; Tageldin, GN | 1 |
| Abdellatif, KRA; El-Magd, MA; Elshaier, YAMM; Fadaly, WAA; Kamel, GM | 1 |
| AboulMagd, AM; Gouda, AM; Mekhlef, YO | 1 |
6 other study(ies) available for celecoxib and thiazolidines
| Article | Year |
|---|---|
Synthesis and characterization of celecoxib derivatives as possible anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV agents.
Topics: Animals; Antineoplastic Agents; Antioxidants; Antiviral Agents; Catalytic Domain; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Edema; Female; Hepacivirus; Hindlimb; Humans; Isothiocyanates; Lipid Peroxidation; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Protein Binding; Pyrazoles; Stomach Ulcer; Sulfonamides; Sulfonylurea Compounds; Thiazolidines; Viral Nonstructural Proteins | 2013 |
Design, synthesis and biological screening of new 4-thiazolidinone derivatives with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Topics: Animals; Anti-Inflammatory Agents; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edema; Humans; Ibuprofen; Mice; Molecular Docking Simulation; Sheep; Stomach Ulcer; Sulfonamides; Thiazolidines | 2016 |
Discovery of a COX-2 selective inhibitor hit with anti-inflammatory activity and gastric ulcer protective effect.
Topics: Animals; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Discovery; Humans; Male; Molecular Docking Simulation; Molecular Structure; Rats; Stomach Ulcer; Structure-Activity Relationship; Thiazolidines | 2017 |
Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Drug Design; Edema; Female; Granuloma; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazolidines | 2018 |
Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
Topics: alpha-Glucosidases; Animals; Anti-Inflammatory Agents; Catalytic Domain; Celecoxib; Cellulases; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Design; Glycoside Hydrolase Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; PPAR gamma; Pyrroles; Rats; Sheep; Stomach Ulcer; Structure-Activity Relationship; Thiazolidines | 2019 |
Design, Synthesis, Molecular docking, and biological evaluation of novel 2,3-diaryl-1,3-thiazolidine-4-one derivatives as potential anti-inflammatory and cytotoxic agents.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Celecoxib; Cyclooxygenase 2; Cytotoxins; Drug Design; Molecular Docking Simulation; Molecular Structure; Rats; Structure-Activity Relationship; Thiazolidines | 2023 |